TTOO T2 Biosystems Inc
51,017
$5.64
$0.33
(5.53%)
| Watchers | 51,017 |
| 52-Wk Low | $2.60 |
| 52-Wk High | $70.00 |
| Market Cap | $86.66M |
| Volume | 582.00 |
| 52-Wk High | $70.00 |
| 52-Wk Low | $2.60 |
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below 200-Day Moving Average of $13.76Zolmax • about 2 months ago
T2 Biosystems, Inc. (NASDAQ:TTOO - Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $13.76 and...
Share to Feed
T2 Biosystems (TTOO) has shared an announcement. The Company has announced the extension of its capital equipment supplier agreement with Vizient...
T2 Biosystems extends contract with Vizient...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the Company ), a leader in the...
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the Company ), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes...
Study demonstrates T2Resistance Panel utilization enables faster targeted therapy based on direct-from-blood detection of resistance genesLEXINGTON, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- T2...
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...